PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases

PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases

Therapeutic strategies for epithelial ovarian cancers are evolving with the advent of immunotherapy, such as PD-L1 inhibitors, with encouraging results. However, little data are available on PDL-1 expression in ovarian cancers. Thus, we set out to determine the PD-L1 expression according to histolo...

Full description

Bibliographic Details
Main Authors: Caroline Eymerit-Morin, Anna Ilenko, Thomas Gaillard, Justine Varinot, Eva Compérat, Sofiane Bendifallah, Emile Darai
Format: Article
Language:English
Published: PAGEPress Publications 2021-03-01
Series:European Journal of Histochemistry
Subjects:
Ovarian cancer
PD-L1 antibody
immunochemistry
histological subtype
Online Access:https://ejh.it/index.php/ejh/article/view/3185

Internet

https://ejh.it/index.php/ejh/article/view/3185

Similar Items